Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
11/17/2004 | CN1175884C Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof |
11/17/2004 | CN1175865C Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof |
11/17/2004 | CN1175845C Chinese traditional medicinal decoction for treating women's genital system diseases |
11/17/2004 | CN1175843C Plaster for treating mastoplasia |
11/17/2004 | CN1175840C Prescription and preparing process of medicine 'Rukang' for treating mastitis |
11/17/2004 | CN1175831C Chinese traditional medicine tincture and its preparation |
11/17/2004 | CN1175828C Medicinal composition for relieving sexual fatigue and delaying senility and preparing process thereof |
11/16/2004 | US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction. |
11/16/2004 | US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders |
11/16/2004 | US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
11/16/2004 | US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
11/16/2004 | US6817317 Animal papilla disinfectants and method of improving microbial environment |
11/11/2004 | WO2004096802A2 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
11/11/2004 | WO2004096240A1 Anthocyanins useful for the treatment of diabetes, cardiovascular disorders and to lower the risk of adverse effects of hormone replacement therapy |
11/11/2004 | WO2004096232A1 Interleukin-8 enhancer |
11/11/2004 | WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
11/11/2004 | WO2003087411A8 Method to inhibit cell growth using oligonucleotides |
11/11/2004 | US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
11/11/2004 | US20040225123 Substituted phenyl naphthalenes as estrogenic agents |
11/11/2004 | US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
11/11/2004 | US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
11/11/2004 | US20040224993 Diphenylurea compounds |
11/11/2004 | US20040224985 for controlling weight; pyrrolidine or piperidine compounds |
11/11/2004 | US20040224970 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
11/11/2004 | US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds |
11/11/2004 | US20040224945 Novel substituted pyrazole derivatives |
11/11/2004 | US20040224938 Substituted benzo [b] azepin-2-one compounds |
11/11/2004 | US20040224911 Transporters and ion channels |
11/11/2004 | US20040224895 a synergistic mixture of Leutenizing Hormone or Human chorionic gonadotrophin and Follicle stimulating hormone to promote folliculogenesis in anovulatory women; improved fertility |
11/11/2004 | US20040224878 Fertilization of aged oocytes |
11/11/2004 | US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents |
11/11/2004 | US20040224314 G-protein coupled receptors |
11/11/2004 | US20040224023 Compositions and methods for treating or preventing diseases of body passageways |
11/11/2004 | CA2524125A1 Antibiotic tetrahydro-.beta.-carboline derivatives |
11/10/2004 | EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
11/10/2004 | EP1475099A1 Use of botulinum toxin to treat urinary incontinence |
11/10/2004 | EP1475098A1 High-concentration preparation of soluble thrombomodulin |
11/10/2004 | EP1475086A2 Sibutramine metabolites |
11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
11/10/2004 | EP1474442A2 Cytotoxic t-cell epitopes from chlamydia |
11/10/2004 | EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
11/10/2004 | EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent |
11/10/2004 | EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents |
11/10/2004 | EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
11/10/2004 | EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists |
11/10/2004 | EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents |
11/10/2004 | EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
11/10/2004 | EP1474069A1 Control of a biological function |
11/10/2004 | EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE |
11/10/2004 | CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists |
11/10/2004 | CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity |
11/10/2004 | CN1545415A Bone anabolic compounds and methods of use |
11/10/2004 | CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
11/10/2004 | CN1545408A Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
11/10/2004 | CN1544596A Male sexual function lotion and preparing process thereof |
11/10/2004 | CN1544471A Bovine mastitis resistant yolk antibody and its preparation method and formulation |
11/10/2004 | CN1544461A Uro-genital condition treatment system |
11/10/2004 | CN1544085A Reproduction rate increasing preparation and its making method for cow and ewe |
11/10/2004 | CN1544073A Chinese traditional medicine capable of invigorating yang and strengthening qi and its preparation |
11/10/2004 | CN1544055A Oil of aromatic turmeric dripping pills and its preparing process |
11/10/2004 | CN1544050A Externally used Shueryin lotion for treating colpitis and its preparation |
11/10/2004 | CN1544042A Liuwei Dihuang dripping pills and its preparation |
11/10/2004 | CN1544027A Menalgia treating Chinese traditional medicine |
11/10/2004 | CN1544020A Chinese patent drug for treating menalgia and barrenness |
11/10/2004 | CN1544012A Externally used yang-strengthening liquor capable of resisting human immunodeficiency virus and its preparation |
11/10/2004 | CN1544004A Chinese traditional medicine perfusate for preventing and treating female livestock barrenness |
11/10/2004 | CN1543988A Chinese traditional medicine Wudu San for treating ovary cyst |
11/10/2004 | CN1543982A Chitose antibacterial film of uterine neck |
11/10/2004 | CN1174770C External medicine for curing gynaecological inflammation and its preparing method |
11/10/2004 | CN1174765C Composite Chinese medicine for treating venereal disease and dermatosis and its preparing method |
11/10/2004 | CN1174759C External application ointment for curing sterility and its preparation method |
11/09/2004 | US6815534 Tissue plasminogen activator-like protease |
11/09/2004 | US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
11/09/2004 | US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
11/09/2004 | US6815438 Heteroaryl-diazabicycloalkanes |
11/09/2004 | US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine. |
11/09/2004 | US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
11/04/2004 | WO2004094451A2 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
11/04/2004 | WO2004093887A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections |
11/04/2004 | WO2004093857A1 Composition for relieving unpleasant symptoms accompanying change in protesterone |
11/04/2004 | WO2004069232A3 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction |
11/04/2004 | WO2003077847A3 Substituted amides |
11/04/2004 | WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists |
11/04/2004 | US20040220408 As anti-proliferative agents, therapy |
11/04/2004 | US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives |
11/04/2004 | US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
11/04/2004 | US20040220205 Parkinson's disease; restless leg syndrome; sexual disorders |
11/04/2004 | US20040220188 Alkylidene pyrazolidinedione derivatives |
11/04/2004 | US20040220175 (Pyrido/thieno) - [f] - oxazepine-5-one derivatives |
11/04/2004 | US20040220163 Contraceptive method and composition |
11/04/2004 | US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders |
11/04/2004 | US20040220133 Composition and method for inhibiting platelet aggregation |
11/04/2004 | US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
11/04/2004 | US20040220088 Multiple domain glycoprotein hormones and methods of using |
11/04/2004 | US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy |
11/04/2004 | US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility |
11/04/2004 | US20040219220 Therapeutic agents |
11/04/2004 | US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
11/04/2004 | US20040219174 Contraception process and administration form for the same |
11/04/2004 | US20040219123 recrystallization-resistant; also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7; preventing/treating the chronological or actinic skin aging and atrophy of the skin or mucous membranes |